Know whether the science stands up before you commit the capital.

De-risk your assay. Protect your runway.

Strengthen your investment case.

ORIVISE helps diagnostics founders, research teams and investors assess assay feasibility, expose hidden technical risks and strengthen the evidence needed for confident development, funding and investment decisions.

De-risk your technology
Audit a data room
Assay chemistry & bioconjugation Development-readiness assessment Pre-investment technical due diligence

Who we work with

Scale-ups and SMEs — diagnostics and laboratory-based life-science companies turning strong science into a compliant, market-ready product.
Early-stage IVD startups and founders — preparing for investment, development or CDMO transfer.
VCs, angels and investment partners — needing independent technical due diligence before committing capital.
Academic labs, biohubs and university spin-outs — preparing for grant-led translation or industry engagement.

THE ORIVISE TRANSLATION LAYER

Connecting assay science to development and capital decisions.

ORIVISE sits between promising early data and the decisions that determine whether a diagnostic programme should progress, pause, refine or seek further investment.

Assay Feasibility

Review assay architecture, reagent design, bioconjugation strategy, data quality and hidden technical risks.

Development Readiness

Assess reproducibility, robustness, evidence gaps, transfer risk and readiness for structured development.

Investment Readiness

Support technical due diligence, data room review, grant-led translation and partner confidence.

Outcome: reduced technical debt, stronger development decisions and clearer investor or partner confidence.